Callan Family Office LLC Sells 343 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Callan Family Office LLC has significantly reduced its stake in Mettler-Toledo International, Inc., owning only 200 shares after a 63.2% decrease during the first quarter, which is valued at approximately $236,000.
• Insider trading activity showed that Directors Michael A. Kelly and Thomas P. Salice sold a combined total of 2,424 shares worth nearly $3 million over the last quarter, indicating a substantial decrease in their ownership.
• Equities analysts remain cautiously optimistic about Mettler-Toledo with a consensus rating of "Hold" and a target price averaging $1,288.89, despite recent decreases in growth forecasts by some firms.

Callan Family Office LLC lessened its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 63.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 200 shares of the medical instruments supplier's stock after selling 343 shares during the period. Callan Family Office LLC's holdings in Mettler-Toledo International were worth $236,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in MTD. Zions Bancorporation National Association UT acquired a new stake in Mettler-Toledo International in the first quarter valued at approximately $43,000. Golden State Wealth Management LLC grew its stake in Mettler-Toledo International by 583.3% in the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 35 shares during the period. Menard Financial Group LLC acquired a new stake in Mettler-Toledo International in the fourth quarter valued at approximately $67,000. Blue Trust Inc. grew its stake in Mettler-Toledo International by 520.0% in the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after acquiring an additional 52 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after acquiring an additional 25 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on MTD shares. Citigroup lifted their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research report on Thursday. Bank of America lifted their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Wall Street Zen cut Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Finally, Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research report on Monday, May 5th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International presently has an average rating of "Moderate Buy" and a consensus price target of $1,311.11.

Mettler-Toledo International Stock Down 3.0%

MTD stock traded down $39.4530 during midday trading on Thursday, hitting $1,277.4270. The company's stock had a trading volume of 138,895 shares, compared to its average volume of 169,643. The stock's 50-day moving average price is $1,224.30 and its 200 day moving average price is $1,189.23. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01. The stock has a market cap of $26.31 billion, a price-to-earnings ratio of 32.35, a PEG ratio of 3.95 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same quarter in the previous year, the firm earned $9.65 earnings per share. The business's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,889 shares of company stock worth $3,603,054 in the last ninety days. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.